BioRem Inc. (TSXV:BRM)

BioRem Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 11, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	33	49	16	14	14	21
Market Cap Growth	12.93%	213.21%	15.10%	-2.10%	-33.28%	35.00%
Enterprise Value	29	46	17	15	5	12
Last Close Price	2.08	3.05	1.00	0.88	0.90	0.54
PE Ratio	12.81	16.15	7.20	8.46	10.74	9.99
PS Ratio	0.87	1.31	0.62	0.47	0.57	0.86
PB Ratio	3.05	4.63	2.34	3.02	7.09	1.54
P/TBV Ratio	3.05	4.63	2.34	3.02	7.09	1.54
P/FCF Ratio	7.55	14.84	-	10.98	3.76	6.96
P/OCF Ratio	7.00	13.34	32.03	9.44	3.68	6.24
EV/Sales Ratio	0.75	1.22	0.67	0.52	0.19	0.47
EV/EBITDA Ratio	5.74	9.76	5.14	5.01	1.90	4.83
EV/EBIT Ratio	6.48	10.38	5.46	5.21	2.02	5.08
EV/FCF Ratio	6.52	13.77	-	12.09	1.27	3.84
Debt / Equity Ratio	0.29	0.34	0.62	1.05	2.88	0.06
Debt / EBITDA Ratio	0.63	0.73	1.21	1.47	2.12	0.32
Debt / FCF Ratio	0.71	1.07	-	3.82	1.53	0.28
Asset Turnover	1.49	1.42	1.12	1.45	1.19	1.23
Inventory Turnover	14.71	14.38	20.28	22.46	19.76	15.57
Quick Ratio	1.45	1.34	1.18	1.24	1.10	2.11
Current Ratio	1.73	1.63	1.41	1.38	1.22	2.34
Return on Equity (ROE)	33.38%	35.10%	38.78%	49.75%	16.75%	16.55%
Return on Assets (ROA)	10.81%	10.44%	8.61%	9.02%	7.09%	7.15%
Return on Capital (ROIC)	21.52%	21.89%	19.12%	21.30%	13.27%	10.82%
Return on Capital Employed (ROCE)	33.20%	32.60%	30.30%	36.90%	39.30%	16.00%
Earnings Yield	9.43%	6.19%	13.88%	11.83%	9.31%	10.01%
FCF Yield	13.25%	6.74%	-0.40%	9.10%	26.60%	14.37%
Buyback Yield / Dilution	6.76%	-0.59%	10.72%	53.08%	5.32%	-2.20%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.